Can B Corp (NASDAQ:CANB) — Market Cap & Net Worth
Market Cap & Net Worth: Can B Corp (CANB)
Can B Corp (NASDAQ:CANB) has a market capitalization of $2.23 Million ($2.23 Million) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29851 globally and #6009 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Can B Corp's stock price $0.03 by its total outstanding shares 75842000 (75.84 Million). Review CANB total liabilities to assess the company's total debt and financial obligations.
Can B Corp Market Cap History: 2015 to 2025
Can B Corp's market capitalization history from 2015 to 2025. Data shows change from $2.48 Billion to $2.23 Million (-51.93% CAGR).
Can B Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Can B Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.95x
Can B Corp's market cap is 0.95 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.48 Billion | $103.04K | -$3.85 Million | 24067.95x | N/A |
| 2016 | $659.83 Million | $95.14K | -$665.05K | 6934.95x | N/A |
| 2017 | $762.21 Million | $122.75K | -$2.14 Million | 6209.67x | N/A |
| 2018 | $1.87 Billion | $668.60K | -$4.11 Million | 2790.46x | N/A |
| 2019 | $293.51 Million | $2.31 Million | -$4.59 Million | 127.31x | N/A |
| 2020 | $49.30 Million | $1.71 Million | -$5.72 Million | 28.83x | N/A |
| 2021 | $37.92 Million | $4.60 Million | -$12.17 Million | 8.24x | N/A |
| 2022 | $98.59 Million | $6.69 Million | -$14.92 Million | 14.75x | N/A |
| 2023 | $2.05 Million | $2.16 Million | -$9.74 Million | 0.95x | N/A |
Competitor Companies of CANB by Market Capitalization
Companies near Can B Corp in the global market cap rankings as of June 18, 2026.
Key companies related to Can B Corp by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #513 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #560 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #631 globally with a market cap of $43.86 Billion USD ( CN¥299.75 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #634 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #513 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #560 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.27 |
| #631 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $43.86 Billion | CN¥46.99 |
| #634 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.30 |
Can B Corp Historical Marketcap From 2015 to 2025
Between 2015 and today, Can B Corp's market cap moved from $2.48 Billion to $ 2.23 Million, with a yearly change of -51.93%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $2.23 Million | -24.23% |
| 2024 | $2.94 Million | +43.70% |
| 2023 | $2.05 Million | -97.92% |
| 2022 | $98.59 Million | +160.00% |
| 2021 | $37.92 Million | -23.08% |
| 2020 | $49.30 Million | -83.20% |
| 2019 | $293.51 Million | -84.27% |
| 2018 | $1.87 Billion | +144.78% |
| 2017 | $762.21 Million | +15.52% |
| 2016 | $659.83 Million | -73.39% |
| 2015 | $2.48 Billion | -- |
End of Day Market Cap According to Different Sources
On May 18th, 2026 the market cap of Can B Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.23 Million USD |
| MoneyControl | $2.23 Million USD |
| MarketWatch | $2.23 Million USD |
| marketcap.company | $2.23 Million USD |
| Reuters | $2.23 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Can B Corp
Can B Corp. develops, manufactures, and sells hemp biomass derived products containing cannabinoids. The company provides hemp cannabinoid products, including oils, creams, moisturizers, isolate, gel caps, spa products, concentrates, and lifestyle products. It sells its products under the Canbiola and Pure Leaf Oil brands through medical professionals under distribution agreements and its website… Read more